Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.295 USD | +1.55% | -2.54% | -86.08% |
14/05 | Transcript : ENDRA Life Sciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Endra Life Sciences Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.08% | 3.21M | |
+33.36% | 49.46B | |
+1.98% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+12.21% | 26.61B | |
-23.07% | 18.64B | |
+8.37% | 13.16B | |
+30.32% | 12.55B | |
+24.23% | 12.1B |
- Stock Market
- Equities
- NDRA Stock
- News ENDRA Life Sciences Inc.
- HC Wainwright Adjusts Price Target on ENDRA Life Sciences to $5 From $6, Reiterates Buy Rating